NCT01546610

Brief Summary

The present study aims to evaluate the effect of insoles for foot arthritis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Nov 2011

Shorter than P25 for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

March 2, 2012

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 7, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

March 9, 2012

Status Verified

March 1, 2012

Enrollment Period

1 year

First QC Date

March 2, 2012

Last Update Submit

March 8, 2012

Conditions

Keywords

Rheumatoid footfoot paininsolesfoot functionelectronic baropodometerplantar pressuregait analysis

Outcome Measures

Primary Outcomes (1)

  • Visual analog scale of pain in feet during walking (VAS)

    Assessing pain in the feet during walking through a visual analog scale from 0 to 10 centimeter (cm)

    12 months

Secondary Outcomes (9)

  • Foot Function Index (FFI)

    12 months

  • Foot Health Status Questionnaire (FHSQ-Br)

    12 months

  • Health Assessmente Questionnaire (HAQ)

    12 months

  • Visual analog scale of pain in feet at rest (VAS)

    12 months

  • 6-MINUTE WALK TEST

    12 months

  • +4 more secondary outcomes

Study Arms (2)

intervention foot orthoses

EXPERIMENTAL

Ethyl vinyl acetate (EVA) insole with medial arch support and bar retrocapital

Other: insoles intervention

placebo insole

PLACEBO COMPARATOR

Foot orthose with support retrocapital and support of medial arch insole intervention

Other: placebo insole

Interventions

EVA insole with arch support and bar retrocapital

Also known as: Interventional group
intervention foot orthoses

EVA insole flat

Also known as: control group
placebo insole

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with established diagnosis RA according to criteria of the American College of Rheumatology (ACR) functional classes I, II and III
  • Foot pain with VAS between 3 - 8 cm for walking
  • Age 18-65 years
  • Basic medication stable for at least three months
  • Not made infiltrations in feet and ankles in the last three months and not during the study
  • Agreed to participate and signed term of informed consent

You may not qualify if:

  • Other musculoskeletal disorders in symptomatic lower limbs
  • Diseases of the central and peripheral nervous system
  • Decompensated diabetes mellitus
  • No walking
  • Rigid deformities in the feet
  • Use of insoles in the last three months
  • Surgery scheduled in the next 12 months
  • Allergy to the material
  • Mental deficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Emilia Moreira

São Paulo, São Paulo, Brazil

RECRUITING

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Control Groups

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • EMILIA MOREIRA, PT

    Federal University of São Paulo

    PRINCIPAL INVESTIGATOR
  • ANAMARIA PT JONES, PHD

    Federal University of São Paulo

    STUDY DIRECTOR
  • JAMIL NATOUR, PHD

    Division of Rheumatology, Federal University of Sao Paulo

    STUDY CHAIR

Central Study Contacts

Jamil MD Natour, PHD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Effect of rheumatoid foot insole

Study Record Dates

First Submitted

March 2, 2012

First Posted

March 7, 2012

Study Start

November 1, 2011

Primary Completion

November 1, 2012

Study Completion

November 1, 2012

Last Updated

March 9, 2012

Record last verified: 2012-03

Locations